Renata Zrinski Topic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Renata Zrinski Topic has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Slavica Dodig
Department of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
6 shared publications - Ivana Cepelak
Department of Medical Biochemistry and Hematology, School of Pharmacy and Biochemistry, University of Zagreb, Zagreb
3 shared publications - Jasna Lenicek Krleza
Department of Laboratory Diagnostics, Children’s Hospital Zagreb, 10000 Zagreb, Croatia
3 shared publications Slavica Dodig
3 shared publicationsIvka Zoričić-Letoja
2 shared publicationsJadranka Živčić
2 shared publications
Latest Publications
- Open Access
- 13 January 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (2) , 165
Cardiac Markers in Pediatric Laboratory Medicine: Critical Review
Currently, there are no validated guidelines or recommendations for how to interpret cardiac biomarkers in the pediatric population. The most commonly used cardiac biomarkers are cardiac troponins and natriuretic peptides, but the clinical value of common cardiac biomarkers in pediatric laboratory medicine is restricted due to age- and sex-specific interpretations, and there are no standardized cut-off values. The results from the studies on reference values, as well as results from clinical studies, are difficult to compare with identical studies due to the heterogeneity of subject characteristics (gestational and chronological age, sex, pubertal status, menstrual cycle, exercise), assay characteristics (type of assay, generation of assay, analytical platform used), and experimental protocol characteristics (prospective or retrospective studies, reference population selection, patient population selection, inclusion and exclusion criteria, number of subjects). Future studies need to establish evidence-based cut-offs for specific indications to optimize utilization and standardize the interpretation of common cardiac biomarkers in neonates, children, and adolescents. The aim of this article was to summarize the current analytical and clinical limitations of cardiac troponins and natriuretic peptides in the pediatric population, as informed by the existing published literature.
- 13 January 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (2) , 165
Open AccessCardiac Markers in Pediatric Laboratory Medicine: Critical Review
Currently, there are no validated guidelines or recommendations for how to interpret cardiac biomarkers in the pediatric population. The most commonly used cardiac biomarkers are cardiac troponins and natriuretic peptides, but the clinical value of common cardiac biomarkers in pediatric laboratory medicine is restricted due to age- and sex-specific interpretations, and there are no standardized cut-off values. The results from the studies on reference values, as well as results from clinical studies, are difficult to compare with identical studies due to the heterogeneity of subject characteristics (gestational and chronological age, sex, pubertal status, menstrual cycle, exercise), assay characteristics (type of assay, generation of assay, analytical platform used), and experimental protocol characteristics (prospective or retrospective studies, reference population selection, patient population selection, inclusion and exclusion criteria, number of subjects). Future studies need to establish evidence-based cut-offs for specific indications to optimize utilization and standardize the interpretation of common cardiac biomarkers in neonates, children, and adolescents. The aim of this article was to summarize the current analytical and clinical limitations of cardiac troponins and natriuretic peptides in the pediatric population, as informed by the existing published literature.
- Open Access
- 31 May 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (11) , 1166
Clinical and Analytical Comparison of Monoclonal and Polyclonal Immunoassays for Fecal Pancreatic Elastase
Background: Numerous immunoassays have been commercialized to determine pancreatic elastase (PE) in feces in screening for exocrine pancreatic insufficiency (EPI), but how the different assays compare to one another is controversial, especially in the context that all methods use the same cut-off values for interpreting the results obtained on the presence or absence of EPI or the degree of insufficiency if it is present. Our aim was to analytically verify a new method for determining PE, compare the results with a previous method, and verify the declared cut-off values for interpretation of the results. Methods: PE in the stool was assayed using a previous monoclonal enzyme-linked immunosorbent assay (“ScheBo ELISA”) and a new polyclonal particle-enhanced turbidimetric immunoassay (“Bühlmann PETIA”). The direct method comparison of two immunoassays was performed in 40 samples. Clinical comparisons were conducted against each other for the binary determination of “abnormal/normal” elastase levels and the three-way determination of “severe/moderate/no” EPI in 56 samples. The indirect comparison method used external quality assessment (EQA) data to compare the monoclonal and polyclonal immunoassays for PE, and additionally compare the monoclonal ScheBo ELISA to a monoclonal chemiluminescence immunoassay (“DiaSorin CLIA”). Results: Precision in the series and intra-laboratory precision for Bühlmann PETIA met the manufacturer’s specifications for the concentration range of limit/lower values and the range of normal values. The Bühlmann PETIA immunoassay on different analytical platforms yielded comparable results and nearly perfect agreement in the case of three-way classification (kappa = 0.89 with 95%CI from 0.79 to 1.00. ScheBo ELISA tends to generate higher values of pancreatic elastase than the Bühlmann PETIA; agreement between the methods was moderate in the case of binary classification (kappa = 0.43; 95% CI 0.25 to 0.62), and substantial in the case of three-way classification (kappa = 0.62; 95% CI 0.50 to 0.75). EQA data analysis showed a statistically significant difference between ScheBo ELISA and Bühlmann PETIA peer groups (p = 0.031), as well as the DiaSorin CLIA and ScheBo ELISA peer groups (p = 0.010). Conclusion: The ScheBo ELISA and Bühlmann PETIA do not appear to be commutable in the analytical and clinical context. Our data address a discordance between different mono- and polyclonal immunoassays for pancreatic elastase and the potential of misclassification using its universal cut-off values in screening suspected patients for exocrine pancreatic insufficiency.
- 31 May 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (11) , 1166
Open AccessClinical and Analytical Comparison of Monoclonal and Polyclonal Immunoassays for Fecal Pancreatic Elastase
Background: Numerous immunoassays have been commercialized to determine pancreatic elastase (PE) in feces in screening for exocrine pancreatic insufficiency (EPI), but how the different assays compare to one another is controversial, especially in the context that all methods use the same cut-off values for interpreting the results obtained on the presence or absence of EPI or the degree of insufficiency if it is present. Our aim was to analytically verify a new method for determining PE, compare the results with a previous method, and verify the declared cut-off values for interpretation of the results. Methods: PE in the stool was assayed using a previous monoclonal enzyme-linked immunosorbent assay (“ScheBo ELISA”) and a new polyclonal particle-enhanced turbidimetric immunoassay (“Bühlmann PETIA”). The direct method comparison of two immunoassays was performed in 40 samples. Clinical comparisons were conducted against each other for the binary determination of “abnormal/normal” elastase levels and the three-way determination of “severe/moderate/no” EPI in 56 samples. The indirect comparison method used external quality assessment (EQA) data to compare the monoclonal and polyclonal immunoassays for PE, and additionally compare the monoclonal ScheBo ELISA to a monoclonal chemiluminescence immunoassay (“DiaSorin CLIA”). Results: Precision in the series and intra-laboratory precision for Bühlmann PETIA met the manufacturer’s specifications for the concentration range of limit/lower values and the range of normal values. The Bühlmann PETIA immunoassay on different analytical platforms yielded comparable results and nearly perfect agreement in the case of three-way classification (kappa = 0.89 with 95%CI from 0.79 to 1.00. ScheBo ELISA tends to generate higher values of pancreatic elastase than the Bühlmann PETIA; agreement between the methods was moderate in the case of binary classification (kappa = 0.43; 95% CI 0.25 to 0.62), and substantial in the case of three-way classification (kappa = 0.62; 95% CI 0.50 to 0.75). EQA data analysis showed a statistically significant difference between ScheBo ELISA and Bühlmann PETIA peer groups (p = 0.031), as well as the DiaSorin CLIA and ScheBo ELISA peer groups (p = 0.010). Conclusion: The ScheBo ELISA and Bühlmann PETIA do not appear to be commutable in the analytical and clinical context. Our data address a discordance between different mono- and polyclonal immunoassays for pancreatic elastase and the potential of misclassification using its universal cut-off values in screening suspected patients for exocrine pancreatic insufficiency.
- Open Access
SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May–July 2020) and second (December 2020–February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years.
Open AccessSARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May–July 2020) and second (December 2020–February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years.
- Open Access
- 14 June 2020
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 30 (2) , 307-314
Verification of the Canadian Laboratory Initiative on Paediatric Reference Intervals (CALIPER) reference values in Croatian children and adolescents
Verification of the Canadian Laboratory Initiative on Paediatric Reference Intervals (CALIPER) reference values in Croatian children and adolescents
- 14 June 2020
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 30 (2) , 307-314
Open AccessVerification of the Canadian Laboratory Initiative on Paediatric Reference Intervals (CALIPER) reference values in Croatian children and adolescents
Verification of the Canadian Laboratory Initiative on Paediatric Reference Intervals (CALIPER) reference values in Croatian children and adolescents
- 1 March 2011
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 42 (3) , 158-160
Allergen Specific Immunoglobulin E in Children Under 6 Years Old With Total Immunoglobulin E Below 10 kU/L
- 1 March 2011
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 42 (3) , 158-160
Allergen Specific Immunoglobulin E in Children Under 6 Years Old With Total Immunoglobulin E Below 10 kU/L
- 1 February 2011
- Published by Elsevier in Archives of Medical Research
- Vol. 42 (2) , 138-143
Indeterminate Results of QuantiFERON-TB Gold In-Tube Assay in Nonimmunosuppressed Children
- 1 February 2011
- Published by Elsevier in Archives of Medical Research
- Vol. 42 (2) , 138-143
Indeterminate Results of QuantiFERON-TB Gold In-Tube Assay in Nonimmunosuppressed Children
- Open Access
- 1 January 2011
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 21 (2) , 111-121
Eosinophil catonic protein – current concepts and controversies
Eosinophil catonic protein – current concepts and controversies
- 1 January 2011
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 21 (2) , 111-121
Open AccessEosinophil catonic protein – current concepts and controversies
Eosinophil catonic protein – current concepts and controversies
- Open Access
- 1 December 2010
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 41 (12) , 728-730
Urates in Exhaled Breath Condensate of Children With Asthma: Table 1
To determine whether urates as a marker of oxidative stress could be determined in exhaled breath condensate (EBC), and if there are any differences in urate concentrations between asthmatic and healthy children. Exhaled breath condensate was collected using an EcoScreen condenser (Erich Jaeger GmbH, Hoechberg, Germany). Urate measurements were performed by enzymatic color test. Asthmatic children were divided into 2 groups: children with controlled asthma and children with acute exacerbation of asthma. Exhaled breath condensate urate concentration was statistically significantly higher in children with controlled asthma compared with control group and acute exacerbation group. Seven children with acute exacerbation of asthma had unmeasurable urate concentrations. Study results showed EBC to contain a measurable urate concentration, which was significantly higher in children with controlled asthma compared with clinically healthy children and children with acute exacerbation of asthma.
- 1 December 2010
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 41 (12) , 728-730
Open AccessUrates in Exhaled Breath Condensate of Children With Asthma: Table 1
To determine whether urates as a marker of oxidative stress could be determined in exhaled breath condensate (EBC), and if there are any differences in urate concentrations between asthmatic and healthy children. Exhaled breath condensate was collected using an EcoScreen condenser (Erich Jaeger GmbH, Hoechberg, Germany). Urate measurements were performed by enzymatic color test. Asthmatic children were divided into 2 groups: children with controlled asthma and children with acute exacerbation of asthma. Exhaled breath condensate urate concentration was statistically significantly higher in children with controlled asthma compared with control group and acute exacerbation group. Seven children with acute exacerbation of asthma had unmeasurable urate concentrations. Study results showed EBC to contain a measurable urate concentration, which was significantly higher in children with controlled asthma compared with clinically healthy children and children with acute exacerbation of asthma.
- Open Access
- 1 January 2010
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- p. 242-248
Concentration of C-reactive protein, magnesium and calcium in children with acute bronchoconstriction
In childhood, bronchoobstruction is mostly caused by respiratory viral infections. The aim of this study was to find out possible changes in serum concentration of magnesium and calcium (participants in bronchoconstriction), and concentration of C-reactive protein (marker of inflammation) in children with moderate and severe bronchoconstriction, caused by viral respiratory infections.
- 1 January 2010
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- p. 242-248
Open AccessConcentration of C-reactive protein, magnesium and calcium in children with acute bronchoconstriction
In childhood, bronchoobstruction is mostly caused by respiratory viral infections. The aim of this study was to find out possible changes in serum concentration of magnesium and calcium (participants in bronchoconstriction), and concentration of C-reactive protein (marker of inflammation) in children with moderate and severe bronchoconstriction, caused by viral respiratory infections.
- Open Access
- 1 January 2010
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- p. 97-100
Increased IgA in a subject with positive anti-thyroid autoantibodies – a case report
Increased concentrations of antithyroid autoantibodies are found in inflammatory diseases as well as in thyroid autoimmune disorders. The aim of this report is to present increased IgA concentrations in a female patient with positive anti-thyroid autoantibodies. Results throughout 13 months of follow-up are presented.
- 1 January 2010
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- p. 97-100
Open AccessIncreased IgA in a subject with positive anti-thyroid autoantibodies – a case report
Increased concentrations of antithyroid autoantibodies are found in inflammatory diseases as well as in thyroid autoimmune disorders. The aim of this report is to present increased IgA concentrations in a female patient with positive anti-thyroid autoantibodies. Results throughout 13 months of follow-up are presented.